These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

155 related items for PubMed ID: 15582103

  • 1. Dopamine agonists suppress cholinomimetic-induced tremulous jaw movements in an animal model of Parkinsonism: tremorolytic effects of pergolide, ropinirole and CY 208-243.
    Salamone JD, Carlson BB, Rios C, Lentini E, Correa M, Wisniecki A, Betz A.
    Behav Brain Res; 2005 Jan 30; 156(2):173-9. PubMed ID: 15582103
    [Abstract] [Full Text] [Related]

  • 2. Local injections of the 5-hydroxytryptamine antagonist mianserin into substantia nigra pars reticulata block tremulous jaw movements in rats: studies with a putative model of Parkinsonian tremor.
    Carlson BB, Wisniecki A, Salamone JD.
    Psychopharmacology (Berl); 2003 Jan 30; 165(3):229-37. PubMed ID: 12420151
    [Abstract] [Full Text] [Related]

  • 3. Blockade of adenosine A2A receptors antagonizes parkinsonian tremor in the rat tacrine model by an action on specific striatal regions.
    Simola N, Fenu S, Baraldi PG, Tabrizi MA, Morelli M.
    Exp Neurol; 2004 Sep 30; 189(1):182-8. PubMed ID: 15296848
    [Abstract] [Full Text] [Related]

  • 4. Dopamine and adenosine receptor interaction as basis for the treatment of Parkinson's disease.
    Simola N, Fenu S, Baraldi PG, Tabrizi MA, Morelli M.
    J Neurol Sci; 2006 Oct 25; 248(1-2):48-52. PubMed ID: 16780890
    [Abstract] [Full Text] [Related]

  • 5. Tremorolytic effects of safinamide in animal models of drug-induced parkinsonian tremor.
    Podurgiel S, Collins-Praino LE, Yohn S, Randall PA, Roach A, Lobianco C, Salamone JD.
    Pharmacol Biochem Behav; 2013 Apr 25; 105():105-11. PubMed ID: 23360954
    [Abstract] [Full Text] [Related]

  • 6. Validation of the tremulous jaw movement model for assessment of the motor effects of typical and atypical antipychotics: effects of pimozide (Orap) in rats.
    Ishiwari K, Betz A, Weber S, Felsted J, Salamone JD.
    Pharmacol Biochem Behav; 2005 Feb 25; 80(2):351-62. PubMed ID: 15680188
    [Abstract] [Full Text] [Related]

  • 7. In vitro and in vivo characterization of F-97013-GD, a partial 5-HT1A agonist with antipsychotic- and antiparkinsonian-like properties.
    Zazpe A, Artaiz I, Innerárity A, Del Olmo E, Castro E, Labeaga L, Pazos A, Orjales A.
    Neuropharmacology; 2006 Jul 25; 51(1):129-40. PubMed ID: 16643965
    [Abstract] [Full Text] [Related]

  • 8. Differential effects of adenosine antagonists in two models of parkinsonian tremor.
    Trevitt J, Kawa K, Jalali A, Larsen C.
    Pharmacol Biochem Behav; 2009 Nov 25; 94(1):24-9. PubMed ID: 19602422
    [Abstract] [Full Text] [Related]

  • 9. Extracellular GABA in globus pallidus increases during the induction of oral tremor by haloperidol but not by muscarinic receptor stimulation.
    Collins-Praino LE, Podurgiel SJ, Kovner R, Randall PA, Salamone JD.
    Behav Brain Res; 2012 Sep 01; 234(1):129-35. PubMed ID: 22728308
    [Abstract] [Full Text] [Related]

  • 10. Striatal and nigral D1 mechanisms involved in the antiparkinsonian effects of SKF 82958 (APB): studies of tremulous jaw movements in rats.
    Mayorga AJ, Trevitt JT, Conlan A, Gianutsos G, Salamone JD.
    Psychopharmacology (Berl); 1999 Mar 01; 143(1):72-81. PubMed ID: 10227082
    [Abstract] [Full Text] [Related]

  • 11. Effects of H1 antagonists on cholinomimetic-induced tremulous jaw movements: studies of diphenhydramine, doxepin, and mepyramine.
    Carlson BB, Trevitt JT, Salamone JD.
    Pharmacol Biochem Behav; 2000 Apr 01; 65(4):683-9. PubMed ID: 10764923
    [Abstract] [Full Text] [Related]

  • 12. Conditional neural knockout of the adenosine A(2A) receptor and pharmacological A(2A) antagonism reduce pilocarpine-induced tremulous jaw movements: studies with a mouse model of parkinsonian tremor.
    Salamone JD, Collins-Praino LE, Pardo M, Podurgiel SJ, Baqi Y, Müller CE, Schwarzschild MA, Correa M.
    Eur Neuropsychopharmacol; 2013 Aug 01; 23(8):972-7. PubMed ID: 22947264
    [Abstract] [Full Text] [Related]

  • 13. Neostriatal muscarinic receptor subtypes involved in the generation of tremulous jaw movements in rodents implications for cholinergic involvement in parkinsonism.
    Salamone JD, Correa M, Carlson BB, Wisniecki A, Mayorga AJ, Nisenbaum E, Nisenbaum L, Felder C.
    Life Sci; 2001 Apr 27; 68(22-23):2579-84. PubMed ID: 11392629
    [Abstract] [Full Text] [Related]

  • 14. Tremulous jaw movements induced by the acetylcholinesterase inhibitor tacrine: effects of antiparkinsonian drugs.
    Cousins MS, Carriero DL, Salamone JD.
    Eur J Pharmacol; 1997 Mar 19; 322(2-3):137-45. PubMed ID: 9098680
    [Abstract] [Full Text] [Related]

  • 15. Oral tremor induced by galantamine in rats: a model of the parkinsonian side effects of cholinomimetics used to treat Alzheimer's disease.
    Collins LE, Paul NE, Abbas SF, Leser CE, Podurgiel SJ, Galtieri DJ, Chrobak JJ, Baqi Y, Müller CE, Salamone JD.
    Pharmacol Biochem Behav; 2011 Sep 19; 99(3):414-22. PubMed ID: 21640750
    [Abstract] [Full Text] [Related]

  • 16. The GABA uptake inhibitor beta-alanine reduces pilocarpine-induced tremor and increases extracellular GABA in substantia nigra pars reticulata as measured by microdialysis.
    Ishiwari K, Mingote S, Correa M, Trevitt JT, Carlson BB, Salamone JD.
    J Neurosci Methods; 2004 Dec 30; 140(1-2):39-46. PubMed ID: 15589332
    [Abstract] [Full Text] [Related]

  • 17. Effects of zonisamide on c-Fos expression under conditions of tacrine-induced tremulous jaw movements in rats: a potential mechanism underlying its anti-parkinsonian tremor effect.
    Miwa H, Kubo T, Suzuki A, Kondo T.
    Parkinsonism Relat Disord; 2009 Jan 30; 15(1):30-5. PubMed ID: 18693129
    [Abstract] [Full Text] [Related]

  • 18. Effects of the adenosine A 2A antagonist KW 6002 (istradefylline) on pimozide-induced oral tremor and striatal c-Fos expression: comparisons with the muscarinic antagonist tropicamide.
    Betz AJ, Vontell R, Valenta J, Worden L, Sink KS, Font L, Correa M, Sager TN, Salamone JD.
    Neuroscience; 2009 Sep 29; 163(1):97-108. PubMed ID: 19467297
    [Abstract] [Full Text] [Related]

  • 19. Behavioral and biochemical correlates of the dyskinetic potential of dopaminergic agonists in the 6-OHDA lesioned rat.
    Carta AR, Frau L, Pinna A, Pontis S, Simola N, Schintu N, Morelli M.
    Synapse; 2008 Jul 29; 62(7):524-33. PubMed ID: 18435422
    [Abstract] [Full Text] [Related]

  • 20. The vesicular monoamine transporter (VMAT-2) inhibitor tetrabenazine induces tremulous jaw movements in rodents: implications for pharmacological models of parkinsonian tremor.
    Podurgiel SJ, Nunes EJ, Yohn SE, Barber J, Thompson A, Milligan M, Lee CA, López-Cruz L, Pardo M, Valverde O, Lendent C, Baqi Y, Müller CE, Correa M, Salamone JD.
    Neuroscience; 2013 Oct 10; 250():507-19. PubMed ID: 23867769
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.